Contractile dysfunction in the mouse heart caused by ...

1 downloads 0 Views 1016KB Size Report
rAAV6 harbouring FLAG-PLCβ1b or FLAG-PLCβ1a was delivered by IV (tail-vein) into 6-week old 57Bl/6 .... the PKCα inhibitor Ro-31-8220 (6) (6mg/g/day).
Contractile dysfunction in the mouse heart caused by phospholipase C1b mediated activation of protein kinase C. David R. Grubb, Yi Ma, Jieting Luo, Bryony Crook, Nicola Cooley, Helen Kiriazis, Paul Gregorevic, Xiao-Jun Du and Elizabeth A. Woodcock Molecular Cardiology Laboratory, BakerIDI Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004 Australia.

Introduction.  Phospholipase C (PLC1) subtypes are early signaling enzymes that respond to activation of Gq-coupled receptors by hydrolysing the plasma membrane lipid, phosphatidylinositol(4,5)bisphosphate (PIP2) to inositol(1,4,5)trisphosphate (IP3) and sn-1,2-diacylglycerol (DAG).

PIP2

Gq

PLC1b

Other receptors

PKC

Stretch

PLC1a has a C-terminal PDZ interacting motif, does not target to the plasma membrane in cardiomyocytes, and is therefore not active.

aa1142

NH2-

Mechanism The effect of PLC1b expression in vivo is reminiscent of previous findings regarding a role for PKC in contractile dysfunction(5-8).

ETA-R

1-AR

PLC1 exists as two splice variants (PLC1a and PLC1b) that differ only in the extreme C-terminal sequence.

PLC1b possesses Pro-motifs that are responsible for its targeting to the plasma membrane by association with the scaffolding protein, Shank3 (1, 2). PLC1b is the immediate down stream effector of Gq in cardiomyocytes (3).

IP3 + DAG

PH

EF

Catalytic

C2

PLC1a

Gq

1. PLC1b-induced contractile depression is reversed by PKC inhibition in vivo.

2. PLC1b increases the membrane localization of PKC in cardiomyocytes.

16 weeks post rAAV6 vector delivery, mice were treated for 5 days with the PKC inhibitor Ro-31-8220 (6) (6mg/g/day). Echocardiography was performed before (-Ro) and after (+Ro) treatment. FLAG-PLC1b

Neonatal rat ventricular myocytes (NRVM) were treated with adenoviruses expressing FLAG-PLC1b or FLAG-PLC1a, soluble (s) and membrane (m) fractions prepared. and PKC PKC and PKC content assessed by western blot. Ca2+ (2mM) was added to extracts as a positive control. B. Average of 3 experiments. * p